{
    "clinical_study": {
        "@rank": "13176", 
        "arm_group": [
            {
                "arm_group_label": "Femoral Nerve Block", 
                "arm_group_type": "Active Comparator", 
                "description": "Ropivicaine 0.2% with epinephrine 1:200,000 will be used for patients between 10kg and up to 25kg in weight; ropivicaine 0.5% with epinephrine 1:200,000 will be used for patients greater than or equal to 25kg"
            }, 
            {
                "arm_group_label": "Standard Anesthetic Management", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to prospectively compare post-operative pain relief in\n      pediatric patients undergoing traumatic femur fracture repair who have received either a\n      femoral nerve block with a lateral femoral cutaneous nerve block or a standard anesthetic\n      for analgesia."
        }, 
        "brief_title": "Femoral Nerve Block for Femur Fracture Repair in Pediatrics", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Traumatic Femur Fracture", 
        "condition_browse": {
            "mesh_term": [
                "Femoral Fractures", 
                "Fractures, Bone"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA physical status I or II\n\n          -  Weight greater than or equal to 10kg\n\n          -  Presenting for repair of traumatic femur fracture\n\n        Exclusion Criteria:\n\n          -  ASA physical status > II\n\n          -  Co-morbid diseases (cardiac, pulmonary, neurological disease)\n\n          -  Patients having concomitant procedures\n\n          -  Abnormal neurovascular examination in the injured leg\n\n          -  Presence of vascular compromise in the affected lower extremity\n\n          -  Mechanism of sustained injury via crush injury\n\n          -  Use of therapeutic dose anticoagulants or presence of a bleeding disorder"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01759407", 
            "org_study_id": "IRB12-00820"
        }, 
        "intervention": {
            "arm_group_label": "Femoral Nerve Block", 
            "intervention_name": "Ropivicaine", 
            "intervention_type": "Drug", 
            "other_name": "Naropin"
        }, 
        "intervention_browse": {
            "mesh_term": "Anesthetics"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 23, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43205"
                }, 
                "name": "Nationwide Children's"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Double-blinded, Randomized Comparison of Ultrasound-guided Femoral Nerve Block With Lateral Femoral Cutaneous Nerve Block Versus Standard Anesthetic Management for Traumatic Femur Fracture Repair in the Pediatric Population", 
        "overall_official": {
            "affiliation": "Nationwide Children's", 
            "last_name": "David P Martin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain scores will be assessed.", 
            "measure": "Pain", 
            "safety_issue": "No", 
            "time_frame": "24 hours post-op"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01759407"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Nationwide Children's Hospital", 
            "investigator_full_name": "David P. Martin", 
            "investigator_title": "Clinical Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Narcotic usage", 
                "safety_issue": "No", 
                "time_frame": "24 hours post-op"
            }, 
            {
                "description": "Time from completion of the surgery to endotracheal extubation", 
                "measure": "Extubation", 
                "safety_issue": "No", 
                "time_frame": "1 hour post-op"
            }
        ], 
        "source": "Nationwide Children's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nationwide Children's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}